Endothelin-1 in Congenital Heart Disease

Pediatric Research

Volumn 57, Issue 5, 2005, Pages 16R-20R

  Beghetti, Maurice ^a   Black, Stephen M ^a   Fineman, Jeffrey R ^a  

^a Children s University Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST;

BLOOD VESSEL TONE; CARDIOPULMONARY BYPASS; CELL PROLIFERATION; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; FIBROSIS; HEART HYPERTROPHY; HUMAN; HUMAN TISSUE; LUNG BLOOD VESSEL; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; ENDOTHELIN-1; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; INFLAMMATION; MODELS, BIOLOGICAL; PEPTIDES; PULMONARY CIRCULATION; PULMONARY VEINS; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS;

EID: 17844398020     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/01.PDR.0000160447.83332.13     Document Type: Review

References (50)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415
2. La M, Reid JJ 1995 Endothelin-1 and the regulation of vascular tone. Clin Exp Pharmacol Physiol 22:315-323
3. Fagan KA, McMurtry IF, Rodman DM 2001 Role of endothelin-1 in lung disease. Respir Res 2:90-101
4. Clozel M 2003 Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit? Ann Med 35:605-613
5. Galie N, Manes A, Branzi A 2004 The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61:227-237
6. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, Mikawa H 1991 Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 84:2280-2285
7. Vincent JA, Ross RD, Kassab J, Hsu JM, Pinsky WW 1993 Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am J Cardiol 71:1204-1207
8. Allen SW, Chatfield BA, Koppenhafer SA, Schaffer MS, Wolfe RR, Abman SH 1993 Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 148:519-522
9. Tutar HE, Imamoglu A, Atalay S, Gumus H, Akar N 1999 Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension. Int J Cardiol 70:57-62
10. Ishikawa S, Miyauchi T, Ueno H, Ushinohama H, Sagawa K, Fusazaki N, Sunagawa H, Honda S, Sakai S, Yamaguchi I, et al 1995 Influence of pulmonary blood pressure and flow on endothelin-1 production in humans. J Cardiovasc Pharmacol 26(Suppl 3):S429-S433
11. Shimada K, Takahashi M, Ikeda M, Tanzawa K 1995 Identification and characterization of two isoforms of an endothelin-converting enzyme-1. FEBS Lett 371:140-144
12. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S 1990 Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732
13. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T 1990 Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735
14. Wong J, Vanderford PA, Winters J, Soifer SJ, Fineman JR 1995 Endothelinb receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension. J Cardiovasc Pharmacol 25:207-215
15. Shetty SS, Okada T, Webb RL, DelGrande D, Lappe RW 1993 Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun 191:459-464
16. Wong J, Vanderford PA, Fineman JR, Soifer SJ 1994 Developmental effects of endothelin-1 on the pulmonary circulation in sheep. Pediatr Res 36:394-401
17. Ruwhof C, van der Laarse A 2000 Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 47:23-37
18. Burrows FA, Klinck JR, Rabinovitch M, Bohn DJ 1986 Pulmonary hypertension in children: perioperative management. Can Anaesth Soc J 33:606-628
19. Hoffman JI, Rudolph AM, Heymann MA 1981 Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 64:873-877
20. Wheller J, George BL, Mulder DG, Jarmakani JM 1979 Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation: 60:1640-1644
21. Castaneda AR, Jonas RA, JE M, FL H 1994 Cardiopulmonary bypass, hypothermia and circulatory arrest. In: AR C (ed) Cardiac Surgery of the Neonate and infant. WB Saunders Company, Philadelphia, pp 23-40
22. Fratz S, Geiger R, Kresse H, Roemer G, Hennig M, Sebening W, Hess J 2003 Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance. J Thorac Cardiovasc Surg 126:1724-1729
23. Dschietzig T, Richter C, Bartsch C, Bohme C, Heinze D, Ott F, Zartnack F, Baumann G, Stangl K 2001 Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium. Biochem Biophys Res Commun 289:245-251
24. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ 1993 Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328:1732-1739
25. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, Fineman JR 1995 in utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92:606-613
26. Ovadia B, Reinhartz O, Fitzgerald R, Bekker JM, Johengen MJ, Azakie A, Thelitz S, Black SM, Fineman JR 2003 Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 284:H480-H490
27. Wong J, Reddy VM, Hendricks-Munoz K, Liddicoat JR, Gerrets R, Fineman JR 1995 Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 269:H1965-1972
28. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR 2000 Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47:97-106
29. Black SM, Mata-Greenwood E, Dettman RW, Ovadia B, Fitzgerald RK, Reinhartz O, Thelitz S, Steinhorn RH, Gerrets R, Hendricks-Munoz K, Ross GA, Bekker JM, Johengen MJ, Fineman JR 2003 Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow. Circulation 108:1646-1654
30. Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schafers HJ 2002 Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 105:1034-1036
31. Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, Brimioulle S, McEntee K, Wauthy P, Salmon I, Ketelslegers JM, Naeije R 2003 Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 107:1329-1335
32. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ 1993 Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88:2128-2138
33. Shafique T, Johnson RG, Dai HB, Weintraub RM, Sellke FW 1993 Altered pulmonary microvascular reactivity after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 106:479-486
34. Turner-Gomes SO, Andrew M, Coles J, Trusler GA, Williams WG, Rabinovitch M 1992 Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease. J Thorac Cardiovasc Surg 103:87-97
35. Pearl JM, Wellmann SA, McNamara JL, Lombardi JP, Wagner CJ, Raake JL, Nelson DP 1999 Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function. Ann Thorac Surg 68:1714-1721
36. Carteaux JP, Roux S, Siaghy M, Schjoth B, Dolofon P, Bechamps Y, Mertes PM, Villemot JP 1999 Acute pulmonary hypertension after cardiopulmonary bypass in pig: the role of endogenous endothelin. Eur J Cardiothorac Surg 15:346-352
37. Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SG 1993 Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 106:473-478
38. Pernow J, Wang QD 1997 Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 33:518-526
39. Huang H, Yao T, Wang W, Zhu D, Zhang W, Chen H, Fu W 2003 Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thoracic Surg 76:136-140
40. Roux S, Breu V, Ertel SI, Clozel M 1999 Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 77:364-376
41. Takanashi M, Endoh M 1991 Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 261:H611-H619
42. Pearl JM, Nelson DP, Wagner CJ, Lombardi JP, Duffy JY 2001 Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation. Ann Thorac Surg 72:565-570
43. Reddy VM, Hendricks-Munoz KD, Rajasinghe HA, Petrossian E, Hanley FL, Fineman JR 1997 Post-cardiopulmonary bypass pulmonary hypertension in lambs with increased pulmonary blood flow. A role for endothelin 1. Circulation 95:1054-1061
44. Petrossian E, Parry AJ, Reddy VM, Akkersdijk GP, McMullan DM, Thompson L, Hendricks-Munoz KD, Hallak H, Hanley FL, Fineman JR 1999 Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow. J Thorac Cardiovasc Surg 117:314-323
45. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW 1981 Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 304:497-503
46. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K 1993 Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73:887-897
47. Schulz-Neick I, Li J, Reader JA, Shekerdemian L, Redington AN, Penny DJ 2002 The endothelin antagonist BQ 123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. J Thorac Cardiovasc Surg 124:435-441
48. Greenberg DA, Chan J, Sampson HA 1992 Endothelins and the nervous system. Neurology 42:25-31
49. Simonson MS, Dunn MJ 1993 Endothelin peptides and the kidney. Annu Rev Physiol 55:249-265
50. Ricciardi R, Schaffer BK, Shah SA, Quarfordt SH, Banner BF, Wheeler SM, Donohue SE, Meyers WC, Chari RS 2001 Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury. J Gastrointest Surg 5:322-329